Protect Pharmaceutical Corporation
PRTT · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $26 | $26 | $30 | $31 |
| % Growth | 2.6% | -13.7% | -3% | – |
| Cost of Goods Sold | $12 | $11 | $14 | $9 |
| Gross Profit | $15 | $14 | $16 | $22 |
| % Margin | 55.7% | 56.1% | 53.9% | 71.5% |
| R&D Expenses | $1 | $1 | $1 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $5 | $5 | -$4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $4 |
| Operating Expenses | $6 | $6 | $6 | $0 |
| Operating Income | $9 | $9 | $10 | $22 |
| % Margin | 33.6% | 34.1% | 34.5% | 71.3% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $9 | $9 | $10 | $26 |
| Tax Expense | $2 | $2 | $0 | $0 |
| Net Income | $7 | $7 | $10 | $26 |
| % Margin | 25.2% | 25.6% | 33.8% | 85.1% |
| EPS | 0.12 | 0.11 | 0.18 | 0.45 |
| % Growth | 9.1% | -38.9% | -60% | – |
| EPS Diluted | 0.12 | 0.11 | 0.18 | 0.45 |
| Weighted Avg Shares Out | 57 | 57 | 57 | 57 |
| Weighted Avg Shares Out Dil | 57 | 57 | 57 | 57 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $9 | $9 | $10 | $22 |
| % Margin | 33.6% | 34.1% | 34.5% | 71.3% |